Potent, selective PPAR-γ receptor agonist
Troglitazone(CS-045), PPARγ agonist, is an anti-diabetic thiazolidinedione (TZD) with anti-inflammatory and anti-tumor activity.
A potent antiproliferative, apoptosis inducer, antioxidant, and antiinflammatory agent
| CAS | 97322-87-7 |
|---|---|
| Sinónimos | CS045 | HSCI1_000037 | DTXSID8023719 | Q7844989 | Rezulin (TN) | SR-05000000454-5 | 5-[(4-{[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl)methyl]oxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione | AB00643330-02 | Troglitazone (JAN/USAN/INN) | 5-[ |
| Especificaciones y pureza | Moligand™, ≥96% |
| Condiciones de almacenamiento de almacenamiento | Store at -20°C,Argon charged |
| Enviado en | Ice chest + Ice pads |
| Product Description | Troglitazone(CS-045), PPARγ agonist, is an anti-diabetic thiazolidinedione (TZD) with anti-inflammatory and anti-tumor activity. |
| Pubchem Sid | 504750916 |
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504750916 |
| Solubilidad | Soluble in ethanol (>25 mg/ml) at 50 °C, DMSO (>25 mg/ml), DMF (30 mg/ml), DMSO:PBS (1:6, pH 7.2) (0.1 mg/ml), and water (0.1 mg/ml) at 25 °C. |
| Sensibilidad | Air Sensitive,Heat Sensitive |
| Número Mdl | MFCD00878416 |
| PubChem CID | 5591 |
